Effect of kefir and low-dose aspirin on arterial blood pressure measurements and renal apoptosis in unhypertensive rats with 4 weeks salt diet

Clinical and Experimental Hypertension

Volumn 36, Issue 1, 2014, Pages 1-8

  Kanbak, Güngör ^a   Uzuner, Kubilay ^a   Kuşat Ol, Kevser ^a   Oǧlakçi, Ayşegül ^a   Kartkaya, Kazim ^a   Şentürk, Hakan ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Aspirin; Cathepsin B; High salt diet; Kefir

Indexed keywords

ACETYLSALICYLIC ACID; CASPASE 3; CATHEPSIN B; CATHEPSIN L; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KEFIR; PRORENIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DNA FRAGMENTATION; DRUG EFFECT; ENZYME ACTIVITY; HYPERTENSION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PARENCHYMA; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PULSE PRESSURE; RAT; RENAL PROTECTION; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOPTOSIS; ASPIRIN; BLOOD PRESSURE; CASPASE 3; CATHEPSIN B; CATHEPSIN L; CULTURED MILK PRODUCTS; CYCLOOXYGENASE INHIBITORS; DNA FRAGMENTATION; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE, DIETARY;

EID: 84892568740     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2013.783046     Document Type: Article

References (40)

1. Kwok LO, Bernard MY, Cheung YBM, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49:69-75
2. Vasdev S, Gill V, Longerich L, et al. Salt-induced hypertension in WKY rats: Prevention by a-lipoic acid supplementation. Mol Cell Biochem 2003;254:319-26
3. Haddy FJ. Role of dietary salt in hypertension. Life Sci 2006;79: 1585-92
4. Pollard JM. Protecting your kidneys. Kidney Health Diabetes 2010;14:8
5. High blood pressure and kidney disease. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, U.S. Department of Health and Human Services; 2007
6. Plaut D, Mazzara A. Biomarkers of kidney failure: A brief review. J Contin Educ Topics Issues 2009
7. Darling IM, Morris ME. Evaluation of ''true'' creatinine clearance in rats reveals extensive renal secretion. Pharm Res 1991;8:1318-22
8. Cheng HF, Raymond CH. Cyclooxygenases, the kidney, and hypertension. Hypertension 2004;43:525-30
9. Peterson JG, Lauer MS. Using aspirin and ACE inhibitors in combination: Why the hullabaloö Cleve Clin J Med 2001;68:569-74
10. Roth GG, Calverley DC. Aspirin, platelets, and thrombosis: Theory and practice. Blood 1994;83:885-98
11. Reusser M, McCarran D. Micronutrient effects on blood pressure regulation. Nutr Rev 1994;52:367-75
12. Aihara K, Kajimato O. Effect of powdered fermented milk with lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 2005;24:257-65
13. Florin M, Lo M, Liu KL, Sassard J. Salt sensitivity in genetically hypertensive rats of the Lyon strain. Kidney Int 2001;59:1865-72
14. Korhonen H. Milk-derived bioactive peptides: From science to applications. J Funct Foods 2009;1:177-87
15. Pihlanto A, Virtanen T, Korhonen H. Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk. Int Dairy J 2010;20:3-10
16. Quiró SA, Hernández-Ledesma B, Ramos M, et al. Angiotensinconverting enzyme inhibitory activity of peptides derived from caprine kefir. J Dairy Sci Am Dairy Sci Assoc 2005;88:3480-7
17. Matsuu M, Shichijo K, Okaichi K, et al. The protective effect of fermented milk kefir on radiation induced apoptosis in colonic cyrpt cells of rats. J Radiat Res (Tokyo) 2003;44:111-15
18. Tavernarakis N. Proteolytic pathways in necrotic cell death. BioTech Int 2006;16:1-4
19. Almeida PC, Oliveira V, Chagas JR, et al. Hydrolysis by cathepsin B of fluorescent peptides derived from human prorenin. Hypertension 2000;35:1278-83
20. Hsueh WA, Baxter JD. Human prorenin. Hypertension 1991;17: 469-77
21. Neves FAR, Duncan KG, Baxter JD. Cathepsin B. Is a prorenin processing enzyme. Hypertension 1996;27:514-17
22. Brechler V, Chu WN, Baxter JD, et al. A protease processing site is essential for prorenin sorting to the regulated secretory pathway. J Biol Chem 1996;271:20636-40
23. Fukuda N, Satoh C, Hu WY, et al. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1999;19:1210-17
24. Liu JR, Wang SY, Chen MJ, et al. The anti-Allergenic properties of milk kefir and soymilk kefir and their beneficial effects on the intestinal microflora. J Sci Food Agric 2006;86:2527-33
25. Escribano M, Molero L, López-Farré A, et al. Aspirin inhibits endothelial nitric oxide synthase (eNOS) and Flk-1 (vascular endothelial growth factor receptor-2) prior to rat colon tumour development. Clin Sci 2004;106:83-91
26. Ichihara K, Haneda T, Onodera S, Abiko Y. Inhibition of ischemiainduced subcellular redistribution of lysosomal enzymes in the perfused rat heart by the calcium entry blocker, diltiazem. J Pharmacol Exp Ther 1987;242:1109-13
27. Kirschke H, Wood L, Reisen F. Activity of lysosomal cysteine proteinase during differentiation of rat skeletal muscle. Biochem J 1983;214:871-7
28. Zovein A, Flowers-Ziegler J, Thamotharan S, et al. Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport. Am J Physiol Regul Integr Comp Physiol 2004;286:273-82
29. Atroshi F, Rizzo A, Biese L, et al. Fumonisin B1-induced DNA damage in rat liver and spleen: Effect of pretreatment with coenzyme Q10, L-carnitine, a-Tocopherol and selenium. Pharmacol Res 1999;40:459-67
30. Layne E. Spectrophotometric and turbidimetric methods for measuring proteins. Methods Enzymol 1957;10:447-55
31. Nishiitsutsuji-Uwo JM, Ross BD, Krebs HA. Metabolic activities of the isolated perfused rat kidney. Biochem J 1967;103:852-62
32. Kokko and Tannen, Fluids and Electrolytes, 1986
33. Rout SK, Dutta S, Sengupta M, et al. Anti hypertensive therapy: The concepts of management with herbal and synthetic agents for pulmonary hypertension. Int J Pharm Sci Rev Res 2010;3:72-9
34. Derkx FHM, Tan-Tjiong L, Veld AJM, et al. Activation of inactive plasma renin by tissue kallikreins. J Clin Endocrinol Metab 1979; 49:765-9
35. Wang PH, Do YS, Macaulay L, et al. Identification of renal cathepsin B as a human prorenin-processing enzyme. J Biol Chem 1991;266:12633-8
36. Hamet P, Richard L, Dam TV, et al. Apoptosis in target organs of hypertension. Hypertension 1995;26:642-8
37. Kuwabara Y, Nagai S, Yoshimitsu N, et al. Antihypertensive effect of the milk fermented by culturing with various lactic acid bacteria and a yeast. J Ferment Bioeng 1995;80:294-5
38. Dubey K, Balani DK, Pillai KK. Potential adverse interaction between aspirin and lisinopril in hypertensive rats. Hum Exp Toxicol 2003;22:143-7
39. Savenkov MP, Ivanov SN, Brodskaia SA. Antihypertensive effect of enalapril and lisinopril administered in combination with nonsteroid anti-inflammatory agents. Ter arkh 2001;73:27-31
40. Przewłocka-Kosmala M. The effect of acetylsalicylic acid on hypotensive action of enalapril in hypertensive patients. Przegl Lek 2002;59:76-8.